Collaboration across government agencies, industry, academia, care delivery systems, foundations, philanthropists and patients and across national boundaries is needed to overcome highly lethal cancers, regional and socioeconomic differences in cancer outcomes and inefficiencies in clinical trials and their high failure rates.